Cabaletta Bio, Inc.

CABA

Healthcare Biotechnology

EPS
+53.4%
Free cash flow
−35.7%

Quarter to June 2026, against a year earlier

1.30 0.02 +1.56%
Market cap
$280.4M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
0.00%
Net debt / EBITDA
0.8×
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(101.06%) (126.98%) (156.03%) (93.20%)
ROA
(80.43%) (95.88%) (111.99%) (75.36%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(131.13%) (185.19%) (212.91%) (94.14%)
Free Cash Flow per Share
(1.18) (1.66) (1.28) (1.02)
Free Cash Flow
(120.26) (132.31) (142.84) (153.93)
Other line items

Show all line items

Columns are period end dates